Dolby Family Ventures — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Magnus Medical develops SAINT, an FDA-cleared, accelerated form of TMS (transcranial magnetic stimulation) therapy that uses precision neuromodulation to treat Major Depressive Disorder, including treatment-resistant depression, over a 5-day course.
BiotechDigital HealthMedical DevicesMental HealthBurlingame, US
Nolan Williams(Director)Christian Gormsen(Executive Officer, Director)Vikram Lamba(Executive Officer)
BoardXingjuan Chao(Director)Andrew Firlik(Director)inHeath Lukatch(Director)
Co-investorsJAZZ Venture PartnersRed Tree Venture
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.
BiotechDeep TechHealthtechMedical DevicesSomerville, US
MJ Antonini(Founder, CEO)Nicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)
Co-investorsFuture VenturesGreyMatterVanedge CapitalVanedge Capital Limited PartnershipLIONHEART VENTURES
Niantic Spatial builds real-world foundation models for physical AI, offering capabilities to reconstruct geometrically accurate 3D digital twins, localize devices without relying on GPS via a Visual Positioning System, and interpret 3D environments.
AI & Machine LearningDeep TechRoboticsSan Francisco, US
John Hanke(Executive Officer, Director)Katherine Richard-Dodson(Executive Officer)Christopher Chow(Executive Officer)Thomas Gewecke(Executive Officer)
BoardGilman Louie(Director)inMegan Quinn(Director)
Co-investorsAlsop Louie PartnersJavelin Venture PartnersScopely
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.